COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS) (ENS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04320316
Recruitment Status : Not yet recruiting
First Posted : March 25, 2020
Last Update Posted : May 29, 2020
Ultragenyx Pharmaceutical Inc
Information provided by (Responsible Party):
Hussein Abdul-Latif, University of Alabama at Birmingham

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 15, 2021
Estimated Study Completion Date : December 15, 2021